Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, vomiting on Wegovy is common and expected, particularly in the first few weeks of treatment or after a dose increase. Semaglutide slows how quickly the stomach empties, and that change can tip some people over into nausea that becomes vomiting. It does not mean the medicine is wrong for you. For most people, it settles as the body adjusts — though there are practical steps that make a real difference, and a small number of people do need their prescriber involved. These are prescription-only medicines, and any concerns about how you're tolerating Wegovy should always go back to the clinician who prescribed it.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy works by activating GLP-1 receptors, which among other things slow gastric emptying, food sits in your stomach longer than it normally would. That is partly how it reduces appetite. The same mechanism is also the reason nausea and vomiting appear on the side-effect list.
When you start semaglutide, or when your prescriber moves you to a higher dose, your gut has to adapt to a new pace. Until it does, it can push back, sometimes dramatically. The Wegovy treatment overview goes into more detail on how semaglutide works in the body, but the short version is that vomiting at this stage is the medicine doing exactly what it is supposed to do, just a little too hard for your system right now.
In the STEP 1 trial, gastrointestinal side effects including nausea and vomiting were the most commonly reported, and most were classed as mild to moderate in intensity. The NHS semaglutide medicines page confirms vomiting as a known common side effect and advises reporting anything that worries you to your prescriber or pharmacist.
The vomiting itself may be unavoidable at first, but its severity is often influenced by how and what you eat. A few changes tend to make a measurable difference:
Eat smaller portions. A stomach that empties slowly has less capacity than it did before you started treatment, and eating the same volume you used to can cause real discomfort. Fatty, rich or very spicy foods are particularly hard to handle early on. Eating slowly, putting the fork down between bites, and stopping the moment you feel full (not when the plate is empty) all help.
Stay hydrated between meals rather than drinking a lot with food. Plain water, sipped steadily through the day, reduces the risk of dehydration if you are vomiting and keeps your stomach from feeling overcrowded at mealtimes.
Routine matters too. Many people find it useful to keep their pen in the fridge door and inject on the same day each week, then track how they feel across the days that follow. That pattern helps you spot whether the worst of it clusters around injection day and plan meals accordingly for that window.
If constipation is adding to your gut discomfort, there is some practical guidance on managing bowel changes alongside Wegovy that may be worth reading alongside this.
Most vomiting on Wegovy is an inconvenience rather than a danger. But there are situations where it becomes a clinical matter, not a waiting game.
Contact your GP or prescriber promptly if vomiting is severe, lasts more than a day or two without letting up, or is stopping you from keeping any fluids down. Dehydration is a real risk with sustained vomiting, and it can affect your kidneys in ways that need monitoring.
More urgently: if you develop severe stomach pain that does not ease, particularly pain that radiates towards your back, seek medical help straight away. The MHRA issued a Drug Safety Update in January 2026 highlighting acute pancreatitis as an infrequent but serious risk with GLP-1 medicines; the symptom to watch for is exactly that kind of persistent, intense abdominal pain, with or without vomiting. You can also report side effects through the MHRA Yellow Card scheme if you experience something unexpected.
Vomiting that recurs dose after dose without any settling may be a sign that your titration schedule needs revisiting. That is a conversation with your prescriber, not a decision to make alone. You can explore more detail on vomiting patterns during Wegovy treatment if you want a fuller picture before that conversation.
Not everyone tolerates every dose equally. If vomiting remains a significant problem despite dietary adjustments and giving the dose a reasonable window of a few weeks, a prescriber may consider staying at the current dose longer before titrating upward, rather than pushing through to the next level on schedule. That is a clinical decision based on your specific picture.
It is also worth knowing that some people who struggle with the injection form ask about alternatives. Semaglutide is also available as a once-daily tablet (Wegovy tablets), approved by the MHRA in June 2026, though whether switching would suit you is something to discuss with a clinician rather than assume.
If you are wondering whether what you are experiencing is truly vomiting or something else, the related question of whether Wegovy causes vomiting covers that distinction in more depth. And if you are weighing up the full cost picture of staying on treatment, a UK Wegovy cost comparison sets out what private prescriptions typically include.
At nume, a real clinician reads every consultation, not software processing a form. If you are struggling with side effects on your current treatment or want your options reviewed, speak to our prescribers through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.